May 8 Q1 results highlight "superior potency." June 23 video series calls nimacimab a "new frontier." August 7 Q2 results assert "superior weight rebound profile." Media coverage amplified the narrativeanalyst notes praised potential synergies with GLP-1suntil October 6, 2025
Celebrity and public figure disclosures normalized conversations about prescription weight management
With lower levels of inflammation, the joints and tissues in your back may experience less pain
Dose escalation in PWS must be gradual and monitored by healthcare providers experienced in both GLP-1 management and PWS care
Diabetes Care 45 , 27492752 (2022)
Scientifically, hypoactive sexual desire disorder (HSDD) is linked to neurochemical imbalances, leading to broader impacts on mood and quality of life.[5][8] Some of the most common effects of low sexual desire include: Reduced arousal and lubrication: Without the neurological spark, blood flow to genital tissues decreases, causing discomfort or pain during sex (dyspareunia)